[Federal Register Volume 68, Number 153 (Friday, August 8, 2003)]
[Notices]
[Page 47327]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-20228]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 03160]


Cooperative Agreement for Plague Clinical Trials with Prospect 
International in Madagascar; Notice of Intent To Fund Single 
Eligibility Award

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
intent to fund fiscal year (FY) 2003 funds for a cooperative agreement 
program to evaluate the effectiveness and safety of Gentamicin and 
other antibiotics for the treatment of human plague, to evaluate newly 
available rapid dipstick tests for the diagnosis of human plague, and 
to develop a long-term collaboration between the CDC and Madagascar in 
the area of plague research and prevention. The Catalog of Federal 
Domestic Assistance number for this program is 93.283.

B. Eligible Applicant

    Assistance will be provided only to Prospect International (PI) in 
Antananarivo, Madagascar. No other applications are solicited.
    PI is the most appropriate and qualified non-governmental 
organization in Madagascar to conduct the activities specified under 
this cooperative agreement for the following reasons:
    [sbull] PI has established collaborations with Madagascar health 
authorities on health infrastructure such as the Integrated Disease 
Surveillance and Response (IDSR) strategy.
    [sbull] PI has the requisite expertise for management and 
coordination of the logistics and finances of complicated health 
projects.
    [sbull] PI has the proven ability to successfully collaborate with 
CDC on health research and health infrastructure projects.
    [sbull] PI has established collaborations with the Madagascar 
Ministry of Health as well as other high-level government offices.

C. Funding

    Approximately $145,000 is available in FY 2003 to fund this award. 
It is expected that the award will begin on or before September 15, 
2003, and will be made for a 12-month budget period within a project 
period of up to five years. Funding estimate may change.

D. Where To Obtain Additional Information

    For general comments or questions about this announcement, contact: 
Technical Information Management, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For technical questions about this program, contact: Jacob Kool, 
MD, Ph.D., Division of Vector-Borne Infectious Diseases, National 
Center for Infectious Diseases, Centers for Disease Control and 
Prevention, Rampart Road (Foothills Campus), Fort Collins, CO 80521, 
Telephone: 970-266-3540, E-mail: [email protected].

    Dated: August 4, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-20228 Filed 8-7-03; 8:45 am]
BILLING CODE 4163-18-U